Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tonifying kidney and spleen granules (Bu Shen Jian Pi granules) is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine. It is specifically investigated for the prevention and treatment of chemotherapy-induced myelosuppression in pediatric patients undergoing treatment for malignant tumors, including non-Hodgkin lymphoma and high-risk neuroblastoma. The formulation is designed to support bone marrow function and hematopoietic recovery by adhering to the TCM principles of tonifying the kidney and strengthening the spleen, which are considered vital for blood production and immune health in Chinese medical theory.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tonifying kidney and spleen granules.